You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
《新股消息》雍禾醫療(02279.HK)公開發售超購159倍 一手中籤率15%
阿思達克 12-10 08:26
雍禾醫療(02279.HK)公佈招股結果,每股發售價定爲15.8元,香港公開發售部分錄得超額認購約159.06倍,合共3,776.9萬股發售股份已從國際發售重新分配至香港公開發售。而國際發售部分亦錄得超購約7.39倍。每手500股計,一手中籤率15%,要認購16手即8,000股纔可穩獲一手。該股將於下週一(13日)掛牌。聯席保薦人爲摩根士丹利及中金。 公司是次上市共引入10名基石投資者,合共認購4,721.2萬股公司股份,佔緊隨全球發售完成後的股本約9.08%,包括NCC China A-share Master Fund、清池資本、Hudson Bay Master Fund、LAV Star 及LAV Star Opportunities、易方達、WT Asset Management、Enreal China Master Fund及Forreal China Value Fund、常春藤資產管理、Athos Capital及York Asian Opportunities Investments Master Fund, LP。 是次上市料淨集約13.57億元,約42.1%將用於爲中國境內網絡的現有植髮醫療機構進行擴充和升級;約17.5%用於爲產品及服務創新提供資金;約9.7%用作投資於研發,以前沿技術提升服務體系;約23.4%用作在中國整合行業資源以提升品牌知名度;約1.6%用作結清集團就於2021年5月收購顯赫植髮應付關聯方新絲域的收購代價之未償還結餘;及約5.7%用作營運資金及一般企業用途。
Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account